The fines and penalties for violation of the laws, including imprisonment of corporate executives, which have increased dramatically over the past few years. In addition, government enforcement agencies have publicly announced that there will be an enhanced focus and scrutiny on the pharmaceutical industry to ensure full compliance with the laws.